AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2023
Jul 5, 2023
284_dirs_2023-07-05_a3e2a663-bbf2-4386-9360-12167e9c9b44.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2023-06-30
Reporting Person: Seidman Christine E (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | Phantom Stock | $ | A | 70.4134 | Acquired | Common Stock (70.4134) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 100 | Direct |
Footnotes
F1: 1-for-1
F2: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Capital/Financing Update
2026
May 22
Capital/Financing Update
2026
May 20
Capital/Financing Update
2026
May 18
Capital/Financing Update
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Earnings Release
2026
Apr 30